News for iRhythm Technologies, Inc. (0A7L.L)

SAN DIEGO, July 24, 2025 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating AvidXchange Holdings, Inc., iRhythm Technologies, Inc., Haywar

Summary iRhythm Technologies Inc (IRTC), a prominent digital healthcare company specializing in disease detection, prevention, and prediction, has announced the

SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the second quarter 2025 after the close of trading on Thursday, July 31, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

iRhythm Technologies (IRTC) has recently been the subject of an analyst report by Morgan Stanley. The firm maintained its current "Overweight" rating on the sto

PR NewswireNEW YORK, July 15, 2025 MarketNewsUpdates News CommentaryNEW YORK, July 15, 2025 /PRNewswire/ -- Artificial Intelligence (AI) algorithms are rev

Morgan Stanley's analyst, Kallum Titchmarsh, has revised the price target for iRhythm Technologies (IRTC), reducing it to $147 from a previous $160, while maint

BTIG analyst Marie Thibault has reaffirmed a Buy rating for iRhythm Technologies (IRTC), maintaining a price target of $165. This follows the release of the Cen

Summary On July 7, 2025, iRhythm Technologies Inc (IRTC), a leader in digital healthcare solutions, announced the retirement of two long-serving board members,

SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the retirement of two long-serving board members, Mark Rubash and Ralph Snyderman, M.D., effective July 7, 2025. Concurrently, Karen McGinnis and Kevin O’Boyle have accepted appointments to the board of directors.

iRhythm Technologies, Inc. (NASDAQ:IRTC) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Morgan Stanley has raised its price target on iRhythm Technologies, Inc. (NASDAQ:IRTC) to $160 from $130, while maintaining an “Overweight” rating, citing strong early indicators for the company’s second-quarter performance. In a recent note to investors, […]

iRhythm Technologies (IRTC) has unveiled findings from extensive real-world research at the American Diabetes Association's 85th Scientific Sessions, highlighti

Summary iRhythm Technologies Inc (IRTC) announced significant findings from two large-scale real-world studies at the American Diabetes Association's 85th Scien

An analyst from BTIG, Marie Thibault, has increased the price target for iRhythm Technologies (IRTC) from $140 to $165, maintaining a Buy rating on the stock. T

Summary iRhythm Technologies Inc (IRTC) is currently under investigation by the national law firm Morris Kandinov for potential breaches of fiduciary duties and

SAN DIEGO, June 18, 2025 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating iRhythm Technologies, Inc., Hayward Holdings, Inc., Methode El

SAN DIEGO, June 17, 2025 (GLOBE NEWSWIRE) -- A shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired i

Summary On June 17, 2025, Schubert Jonckheer & Kolbe LLP announced an investigation into iRhythm Technologies Inc (IRTC) regarding potential legal claims. The f

In a recent analysis, Morgan Stanley elevated its price target for iRhythm Technologies (IRTC) to $160, previously set at $130, while maintaining an Overweight

Shares of iRhythm Technologies Inc (IRTC) surged 3.75% in mid-day trading on Jun 3. The stock reached an intraday high of $146.90, before settling at $145.93,